阿伐那非 T2334

Product Introduction
Bioactivity


英文名: Avanafil

描述: Avanafil (TA1790) 是一种高活性PDE-5抑制剂，IC50=5.2 nM，对PDE1，PDE6和PDE11活性较低。

体外活性: 在T2DM大鼠海绵体内,注射 Avanafil（1 μM）能够改善勃起反应不良.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: Ethanol : < 1 mg/mL (insoluble or slightly soluble)
H2O : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 90 mg/mL (186 mM)


关键字: Phosphodiesterase (PDE) | bone density | TA-1790 | Endogenous Metabolite | Inhibitor | osteoporosis | Avanafil | dexamethasone | NOS | Nitric oxide synthases | corpus cavernosum | erectile dysfunction | inhibit | NO Synthase | TA 1790

相关产品: BW-A 78U | Bucladesine sodium | Ayanin | TyK2-IN-2 | Indomethacin | Apremilast | Cilostamide | ATX inhibitor 5 | D159687 | ATX inhibitor 1

相关库: Anti-Neurodegenerative Disease Compound Library | Drug Repurposing Compound Library | Anti-Metabolism Disease Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Highly Selective Inhibitor Library | EMA Approved Drug Library | Metabolism Compound Library | NO PAINS Compound Library | Anti-Alzheimer's Disease Compound Library

阿伐那非 T2334信息由TargetMol中国为您提供，如您想了解更多关于阿伐那非 T2334报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途